GUGGENHEIM CAPITAL LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2015$4,926,000
-3.0%
493,584
+23.7%
0.01%0.0%
Q1 2015$5,078,000
+27.8%
398,911
+42.1%
0.01%
+20.0%
Q4 2014$3,973,000
+9.9%
280,804
+6.8%
0.01%
+11.1%
Q3 2014$3,616,000
-2.2%
262,966
+9.4%
0.01%0.0%
Q2 2014$3,697,000
-26.9%
240,361
-19.0%
0.01%
-35.7%
Q1 2014$5,058,000
+79.9%
296,817
+36.8%
0.01%
+55.6%
Q4 2013$2,811,000
-2.3%
217,031
-23.8%
0.01%
-10.0%
Q3 2013$2,878,000
+59.9%
284,901
+18.2%
0.01%
+25.0%
Q2 2013$1,800,000241,0130.01%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders